Jane Street Group, LLC Aldeyra Therapeutics, Inc. Transaction History

Jane Street Group, LLC

$616 Billion
Q3 2025

A detailed history of Jane Street Group, LLC transactions in Aldeyra Therapeutics, Inc. stock. As of the latest transaction made, Jane Street Group, LLC holds 251,518 shares of ALDX stock, worth $1.28 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

251,518

Previous 96,683 160.15%

Holding current value

$1.28 Million

Previous $370,000 251.35%

% of portfolio

0.0%

Previous 0.0%

22 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$4.0 - $5.89 $619,340 - $911,978	154,835 Added 160.15%	251,518 $1.3 Million
Q2 2025 Aug 14, 2025	SELL	$1.42 - $5.48 $115,626 - $446,219	-81,427 Reduced 45.72%	96,683 $370,000
Q1 2025 May 19, 2025	SELL	$4.7 - $6.98 $44,180 - $65,612	-9,400 Reduced 5.01%	178,110 $1.02 Million
Q1 2025 May 14, 2025	BUY	$4.7 - $6.98 $881,297 - $1.31 Million	187,510 New	187,510 $1.08 Million
Q3 2024 Nov 14, 2024	SELL	$3.19 - $6.32 $221,433 - $438,702	-69,415 Reduced 74.52%	23,731 $127,000

Q2 2024 Aug 14, 2024	BUY	$3.25 - $4.72 $302,724 - $439,649	93,146 New	93,146 $308,000
Q4 2023 Feb 14, 2024	SELL	$1.47 - $6.06 $94,235 - $388,482	-64,106 Reduced 48.41%	68,327 $239,000
Q3 2023 Nov 14, 2023	BUY	$6.11 - $8.16 $475,266 - $634,725	77,785 Added 142.34%	132,433 $884,000
Q2 2023 Aug 14, 2023	SELL	$7.11 - $11.89 $1.53 Million - $2.55 Million	-214,882 Reduced 79.72%	54,648 $458,000
Q1 2023 May 15, 2023	BUY	$5.77 - $9.93 $1.19 Million - $2.05 Million	206,348 Added 326.59%	269,530 $2.68 Million
Q4 2022 Feb 14, 2023	BUY	$5.08 - $7.09 $320,964 - $447,960	63,182 New	63,182 $439,000
Q2 2022 Aug 16, 2022	SELL	$2.43 - $4.85 $161,347 - $322,030	-66,398 Closed	0 $0
Q1 2022 May 17, 2022	SELL	$3.25 - $5.17 $262,788 - $418,035	-80,858 Reduced 54.91%	66,398 $295,000
Q4 2021 Feb 15, 2022	BUY	$3.5 - $9.63 $328,209 - $903,043	93,774 Added 175.34%	147,256 $589,000
Q3 2021 Nov 16, 2021	BUY	$7.94 - $11.31 $319,505 - $455,114	40,240 Added 303.88%	53,482 $469,000
Q2 2021 Aug 16, 2021	SELL	$10.44 - $14.85 $64,759 - $92,114	-6,203 Reduced 31.9%	13,242 $150,000
Q1 2021 May 18, 2021	SELL	$6.53 - $14.42 $399,080 - $881,278	-61,115 Reduced 75.86%	19,445 $231,000
Q4 2020 Feb 17, 2021	BUY	$6.31 - $8.13 $397,851 - $512,604	63,051 Added 360.11%	80,560 $553,000
Q3 2020 Nov 17, 2020	SELL	$4.0 - $7.53 $456,324 - $859,029	-114,081 Reduced 86.69%	17,509 $130,000
Q2 2020 Aug 17, 2020	BUY	$1.97 - $5.05 $259,232 - $664,529	131,590 New	131,590 $549,000
Q4 2017 Feb 15, 2018	SELL	$5.7 - $7.75 $62,477 - $84,947	-10,961 Closed	0 $0
Q3 2017 Nov 14, 2017	BUY	$3.9 - $10.8 $42,747 - $118,378	10,961	10,961 $79,000

Others Institutions Holding ALDX

# of Institutions

143

Shares Held

39.9M

Call Options Held

344K

Put Options Held

71.7K

View Full List

About Aldeyra Therapeutics, Inc.

Ticker ALDX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 58,323,100
Market Cap $296M
Description
Aldeyra Therapeutics, Inc., a biotechnology company, develops and commercializes medicines for immune-mediated ocular and systemic diseases. The company's lead product candidate is reproxalap, a reactive aldehyde species (RASP)modulator, which is in Phase III clinical trial for the treatment of dry eye diseases and allergic conjunctivitis. It al...

More about ALDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.

Account

Jane Street Group, LLC Aldeyra Therapeutics, Inc. Transaction History